Pharmaceutical Executive-06-01-2019

Pharmaceutical Executive

Pharm Exec's Top 50 Companies 2019

July 12, 2019

Features

39

6

Our 19th annual listing reveals some interesting maneuvering of ranks, as companies focus on diversification, big-brand expansions, and positioning a new wave of products to compete in an advancing but complex future treatment market.

Pharma Medical Affairs: A Blueprint for Future

June 24, 2019

Features

39

6

Changing customer preferences and a growing need for specialized knowledge are challenging the traditional scope of the medical affairs function. Learn about six ways pharma MA departments can drive more collaborative relationships with caregivers.

A Critical Juncture for Antibiotic R&D

June 11, 2019

Columns

39

6

With little momentum in developing new new antibiotics to fight antimicrobial resistance, the time is now to emphasize "push" and "pull" incentives and demonstrate how innovation in this area will lead to patient benefit and economic reward.

Pharmaceutical Executive, June 2019 Issue (PDF)

June 01, 2019

Issue PDF

39

6

Click the title above to open the Pharmaceutical Executive June 2019 issue in an interactive PDF format.

Country Report: France

June 01, 2019

Special Sponsored Section

39

6

After several years of losing pace to many of its European peers when it comes to pharma production and R&D, France’s life sciences market, sparked by a renewed spirit of reform, is now squarely back on the radar of the international investor community.